IsoRay, Inc.
350 Hills Street
Suite 106
Richland,
WA 99354
United States - Map
Phone: 509-375-1202
Fax: 509-375-3473
Website: http://www.isoray.com
IsoRay, Inc. engages in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate cancer; ocular melanoma; head, neck, and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer; and pancreatic cancers. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer. IsoRay, Inc. is based in Richland, Washington. Key Statistics
| |
| | Pay | Exercised | Mr. Dwight Babcock ,
65
Chairman and Chief Exec. Officer | 276.00K | 0.00 | Mr. Fredric Swindler ,
66
VP of Regulatory & Quality Affairs, Corp. Sec. and VP of Regulatory Affairs & Quality Assurance for Isoray Medical Inc | 163.00K | 0.00 | Mr. Robert Bilella ,
Ne Area Sales Director | 182.00K | 0.00 | Mr. William Cavanagh III,
47
VP of R&D and VP of R&D for Isoray Medical Inc | 154.00K | 0.00 | Mr. Brien L. Ragle ,
44
Principal Financial & Accounting Officer and Controller | N/A | N/A |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.08%